Scientists are testing a promising drug that may stop a gene associated with obesity from triggering breast and lung cancer, as well as prevent these cancers from growing.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
The human body was thought to have 79 organs—until researchers stumbled on a strange phenomenon that could turn medicine and what we thought we knew about the body upside down.
DNA has an important job—it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off.
A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the UK could be prevented through lifestyle changes.
Researchers have developed a test that provides a safe and minimally invasive method for earlier diagnosis of ovarian and endometrial cancers.
Being obese or having a higher BMI while carrying a BRCA mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research suggests.
With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumours.
Researchers have developed a technique that allowed them to determine at diagnosis whether children with acute lymphoblastic leukaemia would relapse following treatment.
23andMe has received the first-ever FDA authorisation for a direct-to-consumer genetic test for cancer risk for its BRCA1 and BRCA2 report.
Scientists created an odd couple: a modified version of an immune-signalling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.